| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |